Publications by authors named "Vilma Pacheco-Barcia"

Claim this Profile
I
Interventional strategies to address burnout in young medical oncologists: results from the Resilience-Spanish Society of Medical Oncology (SEOM) Study and a university hospital experience in Spain.
Vilma Pacheco-Barcia, Berta Obispo, Elia Tomas, Clara Salva de Torres, Teresa Quintanar

Clin Transl Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiome and nutritional strategies in gastrointestinal cancers: Clinical implications and therapeutic perspectives.
Vilma Pacheco-Barcia, Axel Mariño-Mendez, Enrique Hernandez-Jimenez, Paula Jimenez-Fonseca, Andrés Jesús Muñoz Martín

World J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic mechanisms of immunotherapy resistance.
Luis Cabezón-Gutiérrez, Magda Palka-Kotlowska, Sara Custodio-Cabello, Beatriz Chacón-Ovejero, Vilma Pacheco-Barcia

Explor Target Antitumor Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC).
Sara Custodio-Cabello, Vilma Pacheco-Barcia, Magda Palka-Kotlowska, Laura Fernández-Hernández, Julio Fernández Del Álamo

Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on thymic epithelial tumors: a narrative review.
Luis Cabezón-Gutiérrez, Vilma Pacheco-Barcia, Fátima Carrasco-Valero, Magda Palka-Kotlowska, Sara Custodio-Cabello

Mediastinum· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial.
Vilma Pacheco-Barcia, Sara Custodio-Cabello, Fatima Carrasco-Valero, Magda Palka-Kotlowska, Axel Mariño-Mendez

World J Gastrointest Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.
Manuel Sánchez Cánovas, David Fernández Garay, Francisco Gómez Martínez, Elena Brozos Vázquez, Miriam Lobo de Mena

Clin Transl Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological factors and prognostic communication preferences in advanced cancer: multicentre study.
Avinash Ramchandani, Luka Mihic-Góngora, Raquel Hernández, Marta Zafra-Poves, María M Muñoz, Vilma Pacheco-Barcia

BMJ Support Palliat Care· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma.
Celia Lara-Morga, Magda Palka-Kotlowska, Sara Custodio-Cabello, Vilma Pacheco-Barcia, Luis Cabezón-Gutiérrez

Explor Target Antitumor Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section.
Domingo Antonio Sanchez Martinez, Aliica Quilez-Cutillas, Pablo Jimenez-Labaig, Andrea Sesma, Noelia Tarazona, Vilma Pacheco-Barcia

Clin Transl Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas

Ther Adv Med Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
Jacobo Rogado, Fernando Pozo, Kevin Troulé, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Vilma Pacheco-Barcia

Clin Transl Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of sex on psychological distress, quality of life, and coping of patients with advanced colorectal and non-colorectal cancer.
Vilma Pacheco-Barcia, David Gomez, Berta Obispo, Luka Mihic Gongora, Raquel Hernandez San Gil

World J Gastrointest Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stoic attitude in patients with cancer from the NEOcoping study: Cross-sectional study.
David Gomez, Alberto Carmona-Bayonas, Raquel Hernandez, Oliver Higuera, Jacobo Rogado, Vilma Pacheco-Barcia

PLoS One· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality.
Luka Mihic-Gongora, Paula Jiménez-Fonseca, Raquel Hernandez, Mireia Gil-Raga, Vilma Pacheco-Barcia

BMC Palliat Care· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Jacobo Rogado, Fernando Pozo, Kevin Troule, José Miguel Sánchez-Torres, Nuria Romero-Laorden, Vilma Pacheco-Barcia

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair.
Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, Ana Isabel Ballesteros, Gloria Marquina

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.
Jacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, Ana María Ramos-Levi, Vilma Pacheco-Barcia

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy.
Alberto Carmona-Bayonas, Caterina Calderón, Raquel Hernández, Ana Fernández Montes, Beatriz Castelo, Vilma Pacheco-Barcia

NPJ Breast Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Optimism and social support as contributing factors to spirituality in Cancer patients.
Laura Ciria-Suarez, Caterina Calderon, Ana Fernández Montes, Mónica Antoñanzas, Raquel Hernández, Vilma Pacheco-Barcia

Support Care Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Properties of the PDRQ-9 in Cancer Patients: Patient-Doctor Relationship Questionnaire.
Caterina Calderón, Urbano Lorenzo-Seva, Pere J Ferrando, Ruth Martínez-Cabañes, Oliver Higuera, Vilma Pacheco-Barcia

Psicothema· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer.
Vilma Pacheco-Barcia, Rebeca Mondéjar Solís, Talya France, Jamil Asselah, Olga Donnay

Pancreatology· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systemic Inflammation Response Index Could be a Predictive Factor for mFOLFIRINOX in Metastatic Pancreatic Cancer.
Vilma Pacheco-Barcia, Rebeca Mondéjar Solís, Talya France, Jamil Asselah, Olga Donnay

Pancreas· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents.
Vilma Pacheco-Barcia, Rebeca Mondéjar, Olga Martínez-Sáez, Federico Longo, Jose Andrés Moreno

Clin Colorectal Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome.
Nieves Gómez-León, Vilma Pacheco-Barcia, Ana I Ballesteros, Javier Fraga, Ramon Colomer

Melanoma Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis